Significantly improved outcomes – both in retention and CGI scores - using Long Acting Buprenorphine (LAB-Buvidal) versus treatment as usual for Opioid Dependence in Wales during the Pandemic
Introduction We have been using LAB (Buvidal) in Cardiff after its pandemic use was funded by Welsh Government. Objectives We wished to review the benefits of introducing LAB (Buvidal) into treatment during the pandemic. Methods This service development review of the first 73 patients treated wit...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2022-06-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S092493382202106X/type/journal_article |